ArticleCureus2026
Tricuspid Valve Endocarditis Beyond the Usual Suspects in a Hemodialysis Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Right-sided infective endocarditis (IE) is predominantly less prevalent than left-sided IE in hemodialysis (HD) patients because the left side is attributed to valvular damage from high-pressure circulation, endothelial vascular differences, and exposure to oxygenated blood. Right-sided IE is most commonly associated with intravenous drug use, central venous catheters, or intracardiac devices. However, it is associated with an increased mortality in HD patients. We present a case of an HD patient with no arteriovenous fistula (AVF) infection or history of intravenous drug use, who presented with right-sided IE. A 33-year-old man with a history of diabetes mellitus and end-stage renal disease on HD via an AVF presented with fever and chills after undergoing thrombectomy for right upper extremity brachial vein deep vein thrombosis, so he was discharged on two weeks of vancomycin administered with dialysis. The patient returned two weeks later for recurrent fever despite adherence to his antibiotic therapy. Blood cultures from previous and current admission grew methicillin-sensitive
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.